RecallDepth
Class II Ongoing

Levothyroxine Sodium Tablets USP, 200 mcg, packaged in a) 90-count bottles (NDC 0378-1819-77) and b) 1000-count bottles (NDC 0378-1819-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

Company
Viatris Inc
Recall Initiated
November 18, 2024
Posted
December 18, 2024
Recall Number
D-0122-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
55,032 bottles
Firm Location
Canonsburg, PA, United States

Reason for Recall

Superpotent Drug and Subpotent Drug: potency failures obtained

Distribution

Nationwide within the United States and Puerto Rico

Lot / Code Info

Lot #: a)8179847, Exp. Date July 2025; b) 3203518, Exp. Date July 2025

More recalls by Viatris Inc

View all recalls by this company →

Other recent Class II Drug recalls